The Patent Finder

Savvipharm Inc

Also on record
Records under this name other than the patents Savvipharm Inc holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Savvipharm Inc

PatentTitleStatus Expires Confidence
US 7,750,018Use of carboxiamidotriazole (CAI) orotate in macular degeneration
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,148,339Method of reducing cardiac levels of doxorubicin when given as orotate salt
Term ended
Term ended Jul 31, 2026 · From the USPTO record
Term endedTerm ended Jul 31, 2026From the USPTO record
US 8,802,831Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
Term ended
Ended no later than Jul 31, 2026 · From the USPTO record
Term endedEnded no later than Jul 31, 2026From the USPTO record
US 8,034,823Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
Formerly held
Term ended
Term ended Feb 19, 2026 · From the USPTO record
Term endedTerm ended Feb 19, 2026From the USPTO record
US 8,415,388Pharmaceutical compositions containing paclitaxel orotate
Term ended
Term ended Sep 17, 2025 · From the USPTO record
Term endedTerm ended Sep 17, 2025From the USPTO record
US 7,601,834Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
Term ended
Term ended Aug 24, 2025 · From the USPTO record
Term endedTerm ended Aug 24, 2025From the USPTO record
US 7,378,054Specimen collecting, processing and analytical assembly
Term ended
Term ended Oct 26, 2024 · From the USPTO record
Term endedTerm ended Oct 26, 2024From the USPTO record
US 6,184,227Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
Formerly held
Term ended
Term ended Apr 20, 2019 · From the USPTO record
Term endedTerm ended Apr 20, 2019From the USPTO record
US 6,239,137Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity
Formerly held
Term ended
Term ended Jan 15, 2019 · From the USPTO record
Term endedTerm ended Jan 15, 2019From the USPTO record
US 5,728,707Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
Formerly held
Term ended
Term ended no later than Mar 17, 2018 · Low confidence
Term endedTerm ended no later than Mar 17, 2018Low confidence
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited